Related Experiment Video
Updated: Feb 5, 2026

Pressure Controlled Ventilation to Induce Acute Lung Injury in Mice
Published on: May 5, 2011
Brain-Derived Glia Maturation Factor β Participates in Lung Injury Induced by Acute Cerebral Ischemia by Increasing
Fei-Fei Xu1, Zi-Bin Zhang1, Yang-Yang Wang1
1Institute of Neurological Disease, Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Abstract:
Brain damage can cause lung injury. To explore the mechanism underlying the lung injury induced by acute cerebral ischemia (ACI), we established a middle cerebral artery occlusion (MCAO) model in male Sprague-Dawley rats. We focused on glia maturation factor β (GMFB) based on quantitative analysis of the global rat serum proteome. Polymerase chain reaction, western blotting, and immunofluorescence revealed that GMFB was over-expressed in astrocytes in the brains of rats subjected to MCAO. We cultured rat primary astrocytes and confirmed that GMFB was also up-regulated in primary astrocytes after oxygen-glucose deprivation (OGD). We subjected the primary astrocytes to Gmfb RNA interference before OGD and collected the conditioned medium (CM) after OGD. We then used the CM to culture pulmonary microvascular endothelial cells (PMVECs) acquired in advance and assessed their status. The viability of the PMVECs improved significantly when Gmfb was blocked. Moreover, ELISA assays revealed an elevation in GMFB concentration in the medium after OGD. Cell cultures containing recombinant GMFB showed increased levels of reactive oxygen species and a deterioration in the state of the cells. In conclusion, GMFB is up-regulated in astrocytes after ACI, and brain-derived GMFB damages PMVECs by increasing reactive oxygen species. GMFB might thus be an initiator of the lung injury induced by ACI.
Insights
Acute cerebral ischemia (ACI) up-regulates glia maturation factor beta (GMFB) in astrocytes. Brain-derived GMFB then damages lung endothelial cells, initiating lung injury after ACI.
Area of Science:
- Neuroscience
- Pulmonology
- Cell Biology
Background:
- Brain damage, specifically acute cerebral ischemia (ACI), is known to precipitate lung injury.
- The precise molecular mechanisms linking ACI to lung damage remain incompletely understood.
- Glia maturation factor beta (GMFB) emerged as a potential key mediator from proteomic analysis.
Purpose of the Study:
- To investigate the role of glia maturation factor beta (GMFB) in the pathogenesis of lung injury following acute cerebral ischemia (ACI).
- To elucidate the cellular source and mechanism by which ACI-induced GMFB affects pulmonary microvascular endothelial cells (PMVECs).
Main Methods:
- Established a middle cerebral artery occlusion (MCAO) rat model to simulate ACI.
- Utilized polymerase chain reaction, western blotting, and immunofluorescence to detect GMFB expression in astrocytes.
- Employed oxygen-glucose deprivation (OGD) on primary astrocytes and RNA interference to modulate GMFB levels.
- Assessed PMVEC viability and reactive oxygen species (ROS) production using conditioned medium from treated astrocytes and recombinant GMFB.
Main Results:
- GMFB was significantly over-expressed in astrocytes within the brain following MCAO.
- Primary astrocytes cultured under OGD conditions also showed increased GMFB levels.
- Blocking GMFB in astrocytes improved the viability of co-cultured pulmonary microvascular endothelial cells (PMVECs).
- Recombinant GMFB exposure to PMVECs increased ROS levels and impaired cell status.
Conclusions:
- Glia maturation factor beta (GMFB) is demonstrably up-regulated in astrocytes subsequent to acute cerebral ischemia.
- Brain-derived GMFB directly contributes to pulmonary microvascular endothelial cell (PMVEC) damage by elevating reactive oxygen species (ROS).
- GMFB is identified as a potential initiating factor in ACI-induced lung injury.
More Related Videos
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Induced Pluripotent Stem Cells
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

